tiprankstipranks
Trending News
More News >

PacBio sees FY25 revenue $155M-$170M, consensus $160.7M

The company reiterates its previous financial guidance including: Full-year 2025 revenue to be $155 million to $170 million; Growth in Vega shipments offsetting a year-over-year decline in Revio system shipments with annualized pull-through per Revio system in the low to mid $200,000s range; 2025 non-GAAP gross margin to be between 35% and 40%.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue